U.S. regulators are reexamining infant RSV antibody treatments as safety questions surface, prompting new FDA scrutiny of ...

A new study has found that a significant percentage of adults in the United States have at least one risk factor for severe respiratory syncytial virus (RSV), even as eligibility for the RSV ...

The Food and Drug Administration has launched a safety review of two approved RSV drugs for infants, the latest immunizations ...

The Centers for Disease Control and Prevention have issued a new recommendation to protect babies against RSV. According to the updated guidelines, infants under the age of 8 months should receive a ...

U.S. health regulators informed senior executives at Merck, Sanofi and AstraZeneca last week that their approved protective RSV treatments for infants would face fresh safety scrutiny following ...

Respiratory virus season is upon the United States as the cold weather months set in, meaning cases of COVID-19, influenza and RSV are set to increase. In its annual outlook report, the Centers for ...

Fewer people have gotten vaccinated against respiratory illnesses this season vs. last, according to survey data presented by ...

For people whose autumn agenda includes getting vaccinated against respiratory diseases — COVID-19, flu, and, for some, RSV — this year may be surprisingly routine. Following several confusing months ...

According to a recent report by CIDRAP and the CDC, published on November 24, 2025, viral activity is on the rise, and it's ...